About this trial
Cantabria Cohort stems from a research and action initiative lead by researchers from Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital and University of Cantabria, supported by the regional Goverment. Its aim is to identify and follow up a cohort that would provide information to improve the understanding of the etiology and prognosis of different acute and chronic diseases. The Cantabria Cohort will recruit between 40,000-50,000 residents aged 40-69 years at baseline, representing 10-20% of the target population. Currently, more than 22,000 volunteers have been enrolled. All participants will be invited for a re-assessment every three years, while the overall duration is planned for twenty years. The repeated collection of biomaterials combined with broad information from participant questionnaires, medical examinations, actual health system records and other secondary public data sources is a major strength of its design, which will make it possible to address biological pathways of disease development, identify new factors involved in health and disease, design new strategies for disease prevention, and advance precision medicine. It is conceived to allow access to a large number of researchers worldwide to boost collaboration and medical research.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Participants between 40-69 years of age
Participants who sign the informed consent form
Participants legally residing in Cantabria
Disqualifiers
Participants under 40 years of age and over 69 years of age
Participants not signing the informed consent form
Participants not legally residing in Cantabria
Trial population
Residents in the autonomous community of Cantabria
Trial design
Cohort
Prospective
Treatments tested in this trial
cohort
Other interventionThe Cantabria Cohort will recruit 40,000-50,000 residents aged 40-69 years at baseline
Treatment groups
Trial outcomes
Primary outcomes
Integration and use of real-world data to improve health research
Identifying lifestyle risk factors and their involvement in chronic diseases
Evaluation of geographic and socio-economic disparities in health and healthcare
Assessing biomarkers for the early detection of diseases and disease risks
Sponsors and contacts
Click on the lead sponsor to view all of their trials.